Literature DB >> 8616738

How should we interpret noncompliance with screening mammography?

H Bryant.   

Abstract

Primary care practitioners have an important role to play in recommending breast cancer screening to patients in the target age group. In this issue of CMAJ (see pages 1335 to 1343) Dr. Marie-Dominique Beaulieu and associates report the results of a program designed to maximize utilization of screening mammography. Only two thirds of eligible women for whom screening mammography was prescribed obtained a mammogram within the 2-month study period. However, when taken in context, this compliance rate is fairly encouraging. There are many possible reasons for noncompliance such as a need for more information or for repeated suggestions. Family physicians should not become disheartened in their efforts to increase the use of screening procedures and may find that collaboration with others in giving consistent messages will help to maximize screening rates within their patient population.

Entities:  

Mesh:

Year:  1996        PMID: 8616738      PMCID: PMC1487689     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  3 in total

1.  An epitaph for cervical carcinoma.

Authors:  C J LUND
Journal:  JAMA       Date:  1961-01-14       Impact factor: 56.272

2.  Recruitment activities and sociodemographic factors that predict attendance at a mammographic screening program.

Authors:  S F Hurley; R M Huggins; D J Jolley; D Reading
Journal:  Am J Public Health       Date:  1994-10       Impact factor: 9.308

3.  Breast cancer screening attitudes and behaviors of rural and urban women.

Authors:  H Bryant; Z Mah
Journal:  Prev Med       Date:  1992-07       Impact factor: 4.018

  3 in total
  1 in total

1.  Communication factors in the follow-up of abnormal mammograms.

Authors:  Eric G Poon; Jennifer S Haas; Ann Louise Puopolo; Tejal K Gandhi; Elisabeth Burdick; David W Bates; Troyen A Brennan
Journal:  J Gen Intern Med       Date:  2004-04       Impact factor: 5.128

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.